Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kisspeptin in Women with Hyperprolactinemia
NCT02956447Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Nov 2017
- Primary completion
- Jun 2023
- Countries
- 1
01
Overview
A Phase 2 trial of kisspeptin 112-121 in hyperprolactinemia, Hypogonadism, sponsored by Massachusetts General Hospital. Started Nov 2017; status: completed.
02
Drugs
kisspeptin 112-121
03
Conditions
hyperprolactinemiaHypogonadism
Beyond the preview
Go deeper on NCT02956447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02956447.